RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 05/28/15 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated April 23, 2015 (the "Circular") for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Durham, North Carolina on May 28, 2015 (the "Meeting"). Detailed results of the vote for the election of directors are set out below:
----------------------------------------------------------------------------
Votes % Votes
Name of Nominee Votes For % Votes For Withheld Withheld
----------------------------------------------------------------------------
Dr. Khalid Islam 5,811,119 99.96% 2,467 0.04%
----------------------------------------------------------------------------
Mr. Adrian Haigh 5,067,580 87.17% 746,006 12.83%
----------------------------------------------------------------------------
Mr. Chris A. Rallis 5,067,580 87.17% 746,006 12.83%
----------------------------------------------------------------------------
Mr. Rostislav Raykov 5,067,242 87.16% 746,344 12.84%
----------------------------------------------------------------------------
Mr. Steven D. Skolsky 5,067,572 87.17% 746,014 12.83%
----------------------------------------------------------------------------
Contacts:
Fennec Pharmaceuticals Inc.
Rosty Raykov
Chief Executive Officer
(919) 636-5144
